Bohn, Jan-Paul http://orcid.org/0000-0002-2066-7377
Funding for this research was provided by:
University of Innsbruck and Medical University of Innsbruck
Article History
Received: 13 October 2023
Accepted: 3 November 2023
First Online: 5 December 2023
Conflict of interest
: J.-P. Bohn reports personal fees from AbbVie, Astra-Zeneca, Beigene and Janssen-Cilag for lectures and advisory board participation.